Singapore markets closed

Lifecore Biomedical, Inc. (LFCR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.39+0.04 (+0.63%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.35
Open6.43
Bid6.35 x 400
Ask6.42 x 400
Day's range6.26 - 6.49
52-week range4.13 - 11.46
Volume113,287
Avg. volume206,730
Market cap195.195M
Beta (5Y monthly)1.06
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report

    CHASKA, Minn., April 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that, on April 15, 2024, the Company received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended February 25, 2024 (the “Q3 Form 10-Q”) and its continued delay in filing its Quarter

  • GlobeNewswire

    Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress

    Year-to-date Results Consistent with Prior Expectations; Experiencing Fiscal Second Half Lift Provides Fiscal 2024 Full Year Guidance Commercial Momentum Continues within Development Portfolio Capacity Expansion Projects Progressing CHASKA, Minn., April 01, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today provided a business update, including certain select preli

  • GlobeNewswire

    Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update

    CHASKA, Minn., March 26, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), announced today that Ernst & Young LLP, the Company’s independent registered public accounting firm for the fiscal year ended May 28, 2023, determined that it declined to stand for reappointment as the Company’s independent registered public accounting firm for the Company’s fiscal year ending Ma